Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.
By M. Thompson, J. Aberg, J. Hoy, A. Telenti, C. Benson, P. Cahn, J. Eron, H. Günthard, S. Hammer, P. Reiss and 5 more. Journal of the American Medical Association (JAMA), 2012
730 citations recorded by the source corpus.
Subfields: Infectious Diseases, Virology
View Paper: https://www.semanticscholar.org/paper/d7c08c944ef065d931641c90d17826a306fe4f66
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Virology
Citations in the corpus
- Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools. (2013, methodology): “We used only the pol (PR + RT) region that is usually sequenced for drug resistance testing (Thompson et al., 2012; Vandamme et al., 2011), since this generates the largest datasets for which these tools are designed.”
- Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection. (2013, neutral): “Elevated level of alanine aminotransferase 10 (2) 22 (5)”
- Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada (2013, result): “These findings may lend additional support to the earlier initiation of ART, in accordance with both the DHHS guidelines recommending universal therapy [30] and the 2012 International AIDS Society-USA (IAS-USA) guidelines, which recommend use of ART for all HIV-positive individuals regardless of CD4”